WO2002060469A1 - Anticancer agents - Google Patents
Anticancer agents Download PDFInfo
- Publication number
- WO2002060469A1 WO2002060469A1 PCT/JP2002/000578 JP0200578W WO02060469A1 WO 2002060469 A1 WO2002060469 A1 WO 2002060469A1 JP 0200578 W JP0200578 W JP 0200578W WO 02060469 A1 WO02060469 A1 WO 02060469A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- anticancer agents
- salt
- peptide fragment
- agents
- antigen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-19416 | 2001-01-29 | ||
JP2001019416 | 2001-01-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002060469A1 true WO2002060469A1 (en) | 2002-08-08 |
Family
ID=18885296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/000578 WO2002060469A1 (en) | 2001-01-29 | 2002-01-28 | Anticancer agents |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2002060469A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005041982A1 (en) * | 2003-10-31 | 2005-05-12 | Kurume University | Combination therapy of peptide vaccination and estramustine treatment |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989006692A1 (en) * | 1988-01-12 | 1989-07-27 | Genentech, Inc. | Method of treating tumor cells by inhibiting growth factor receptor function |
EP1050306A1 (en) * | 1998-01-30 | 2000-11-08 | Japan Science and Technology Corporation | CYTOKINE INDUCERS COMPRISING M161Ag |
-
2002
- 2002-01-28 WO PCT/JP2002/000578 patent/WO2002060469A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989006692A1 (en) * | 1988-01-12 | 1989-07-27 | Genentech, Inc. | Method of treating tumor cells by inhibiting growth factor receptor function |
EP1050306A1 (en) * | 1998-01-30 | 2000-11-08 | Japan Science and Technology Corporation | CYTOKINE INDUCERS COMPRISING M161Ag |
Non-Patent Citations (8)
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005041982A1 (en) * | 2003-10-31 | 2005-05-12 | Kurume University | Combination therapy of peptide vaccination and estramustine treatment |
WO2005041981A1 (en) * | 2003-10-31 | 2005-05-12 | Kurume University | Combination therapy of peptide vaccination and estramustine treatment |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999054286A3 (en) | Btk inhibitors and methods for their identification and use | |
CA2326137A1 (en) | Method for stabilizing pharmaceutical compositions by special use of an antioxidant | |
AU2001239182A1 (en) | Semiconductor component which emits radiation, and method for producing the same | |
IL159022A0 (en) | Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis | |
MXPA04005517A (en) | Pharmaceutical compositions in the form of gel or solution based on dihydrotestosterone, preparation method and uses thereof. | |
IL149136A0 (en) | Compositions containing glucoronoxylomannan from basidiomycetes mushrooms and processes for the preparation thereof | |
WO2002080754A3 (en) | Methods for using annexin for detecting cell death in vivo and treating associated conditions | |
AU2003269940A1 (en) | Systems, methods, and compositions for achieving closure of suture sites | |
WO2003059916A8 (en) | Methods for the preparation of alkyl diaryl borinates and complexed diarylborinic acids | |
AU4710499A (en) | Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds | |
WO2001036487A3 (en) | Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby | |
AU2003297318A1 (en) | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476. | |
WO2005037470A3 (en) | Encapsulated nanoparticles, products containing the same, and methods for using the same | |
AU2002359495A1 (en) | Anti-tnf antibodies, compositions, methods and uses | |
AU2003229835A1 (en) | Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier | |
WO2004016283A3 (en) | Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use | |
AU2003243022A1 (en) | 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same | |
WO2004053097A3 (en) | Chemopreventive and therapeutic aspects of polyphenolic compositions and assays | |
AU2002365269A1 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
HK1060129A1 (en) | Novel piperidinecarboxamide derivatives, method f or preparing same and pharmaceutical compositions containing same. | |
WO2002060469A1 (en) | Anticancer agents | |
AU2002330042A1 (en) | Process for the preparation of 1,5-diarylpyrazoles | |
AU2003210054A1 (en) | Anti-rank monoclonal antibodies and pharmaceutical composition containing the same | |
AU3896899A (en) | Compositions for the treatment of tumors, and uses thereof | |
WO2004016640A3 (en) | 5 ANDROSTEN-3β-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |